Skip to content

The latest company news, press releases, and resources about Servier and everything our company has to offer.

Advanced Search
  • servier logo
     
    11.06.2026
    Servier Highlights Growing Neuro-Oncology Portfolio with New Data Across Pediatric and Adult Glioma at SNO 2026
  • servier logo
     
    11.03.2026
    Servier announces top-line results from the pivotal study for sevasemten in Becker muscular dystrophy
  • servier logo
     
    10.19.2026
    Servier Announces First Patients Dosed in Pivotal Phase 2 EMBLEM-1 Cohort Evaluating Emiltatug Ledadotin (Emi-Le) in Adenoid Cystic Carcinoma
  • servier logo
     
    08.18.2026
    Servier’s VORANIGO® (vorasidenib) and TIBSOVO® (ivosidenib) Nominated for 2026 Prix Galien International Awards
  • servier logo
     
    07.13.2026
    Servier completes the acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business
Show 5102550100 per page
Media Contacts

Servier Media Relations
USmediarelations@servier.com

Subscribe